National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Amendment Determination 2002 (No. 1)

Overview

The National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Amendment Determination 2002 (No. 1) was enacted to address issues within the National Health Act 1953 concerning the payment of suppliers for pharmaceutical benefits. This legislative instrument was made by the Acting Assistant Secretary of the Better Medication Management System Implementation Taskforce (BMMS Implementation Taskforce), Department of Health and Ageing, on behalf of the Minister for Health and Ageing, under the authority granted by subsection 99(8) of the National Health Act 1953. The determination aimed to refine the criteria under which suppliers of pharmaceutical benefits are paid, particularly by adjusting the conditions surrounding the validity of Medicare numbers and the circumstances under which payments are made. This was achieved through amendments to the National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Determination 2002, which were effective from 1 July 2002.

Scope and Application

The National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Amendment Determination 2002 (No. 1) applies to suppliers of pharmaceutical benefits under the National Health Act 1953. It specifically targets the conditions under which payments can be made to these suppliers, particularly in relation to the validity of Medicare numbers and the circumstances in which claims can be processed or rejected. The Determination is applicable to the Commonwealth level, influencing the operations of entities such as the Health Insurance Commission, now known as Medicare Australia, and the suppliers of pharmaceutical products. The amendment modifies the National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Determination 2002 to ensure that payments are only made if certain conditions related to the validity and applicability of Medicare numbers are met. The Determination provides explicit criteria for validating Medicare numbers and handling claims that involve discrepancies or expired numbers, thus ensuring the integrity of the pharmaceutical benefits scheme.

Key Provisions

The National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Amendment Determination 2002 (No. 1) amends the National Health (Circumstances for Payment of Supplier of Pharmaceutical Benefits) Determination 2002. Section 3 of the Determination specifies that suppliers of pharmaceutical benefits can be paid under certain conditions, primarily focusing on the validity of Medicare numbers. Specifically, paragraph 5(1)(c) now requires that the Medicare number must pass a validity test for a claim to be processed. Additionally, subparagraph 5(1)(c)(i) clarifies that a claim cannot proceed if the Medicare number fails this test. The amendment further specifies in subparagraph 5(1)(c)(ii) that even if the Medicare number passes the validity test, certain conditions must be met for the claim to be processed. Paragraph 7(c) details the specific scenarios under which a supplier may be paid, including situations where the Health Insurance Commission had previously identified issues with the Medicare number, such as a cancelled card, an expired number, a name mismatch, or the Medicare number being applicable to another person on the card. The Act imposes several obligations on the parties involved, including suppliers of pharmaceutical benefits and the Health Insurance Commission. Suppliers must ensure that the Medicare numbers they submit with claims pass the validity test as outlined in the amended provisions. The Health Insurance Commission is tasked with conducting these validity tests and verifying that the conditions specified in paragraph 7(c) are met before processing a claim. This includes checking for issues such as cancelled Medicare cards, expired numbers, name discrepancies, and cases where a Medicare number is applicable to another person on the card. Failure to comply with these obligations could result in the rejection of claims and denial of payment to the supplier. Under the amended Determination, there are potential civil and criminal consequences for breaches of the conditions specified. If a supplier knowingly submits a claim with an invalid Medicare number, they could face penalties for defrauding the Health Insurance Commission. The maximum penalties for such offences are not explicitly stated in the text provided but are likely to be significant, given the nature of the offence. Additionally, repeated or deliberate non-compliance could lead to further sanctions, including legal action against the supplier or revocation of their status as an approved supplier of pharmaceutical benefits. The Health Insurance Commission also bears the responsibility of ensuring compliance with these provisions, with potential administrative penalties for failing to enforce the rules correctly.